Frontlight ResearchEarly access
Taking people in United StatesNo phase
Technology Assisted Treatment for Trichotillomania
Key facts
- Who runs it
- HabitAware Inc.
- Where
- Kent, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 90 people, planned
- Started
- 15 May 2026
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Keen2 bracelet
- Reminder bracelet
- Keen2 app
- Health Reminders App
- Record updated
- 2 June 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- 18 years of age or older (criterion 1a) with a diagnosis of TTM focused on primary hair pulling location(s) above the neck (e.g., scalp, eyebrows, eye lashes, beard) (criterion 1b)
- English language fluency (criterion 2)
- Report no current pharmacological intervention targeting TTM symptoms OR a 6-week course of the intervention without change in dosage and intent for that dosage to remain stable for the 12 weeks of this trial (criterion 3a)
- Report no current psychosocial intervention targeting TTM (criterion 3b)
- Reliable and consistent access to the internet and/or mobile device permitting the participant to meet with someone virtually for 90 min
- Owns a mobile phone running on Apple's operating system (iOS 6+) 6. Identifies a support person that is able to be contacted if an emergency arises
Who cannot take part
- Current suicidal/homicidal ideation, intent, or plan (criterion 1a) or a diagnosis of another psychiatric condition that may impede a participant's ability to fully utilize the app (e.g., psychotic disorder, eating disorder, moderate to severe major depressive disorder [defined by meeting diagnostic criteria on the MINI and a score >13 on DASS-21]) (criterion 1b)
- Has not used HabitAware's Keen or Keen2 bracelet in the past 24 months
- Residing outside the United States
Where in United States
- Department of Psychological SciencesKent, United StatesContact: Christopher Flessner, PhDTaking people
About the trial
What the trial wants to find out
The investigators are testing two digital health interventions for trichotillomania (TTM), via a randomized trial design.
The 2 groups in the trial
- Keen2 bracelet and appTreatment being tested
8-week intervention involving a wrist-worn motion detection device (Keen2 bracelet) and accompanying smartphone app that delivers components of behavior therapy for TTM.
Treatment: Keen2 bracelet and Keen2 app
- Reminder bracelet and health tips appPlacebo, for comparison
8-week intervention involving a wrist-worn reminder device (non-vibrating bracelet) and accompanying smartphone app that prompts for general context logging and delivers general health tips.
Treatment: Reminder bracelet and Health Reminders App
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 2 June 2026